Julian A. Symons

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Julian A. Symons
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julian A. Symons:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aligos Therapeutics, Inc. Executive Vice President, Chief Scientific Officer Stock Option (Right to Buy) 23,310 09 Mar 2026 Direct

Insider Reports Filed by Julian A. Symons

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALGS Aligos Therapeutics, Inc. 09 Mar 2026 1 $0 4 Executive Vice President, Chief Scientific Officer 11 Mar 2026, 16:19
ALGS Aligos Therapeutics, Inc. 16 Jul 2025 1 $0 4 Executive Vice President, Chief Scientific Officer 18 Jul 2025, 17:14
ALGS Aligos Therapeutics, Inc. 28 Feb 2025 1 $0 4 Executive Vice President, Chief Scientific Officer 04 Mar 2025, 16:33
ALGS Aligos Therapeutics, Inc. 04 Sep 2024 1 $0 4 Executive Vice President, Chief Scientific Officer 06 Sep 2024, 16:22
ALGS Aligos Therapeutics, Inc. 01 Mar 2024 1 $0 4 Executive Vice President, Chief Scientific Officer 04 Mar 2024, 17:42
ALGS Aligos Therapeutics, Inc. 27 Feb 2024 6 $0 4 Executive Vice President, Chief Scientific Officer 28 Feb 2024, 17:31
ALGS Aligos Therapeutics, Inc. 08 Sep 2023 1 $0 4 Executive Vice President, Chief Scientific Officer 12 Sep 2023, 16:06
ALGS Aligos Therapeutics, Inc. 15 Mar 2023 1 $0 4 Executive Vice President, Chief Scientific Officer 17 Mar 2023, 16:11
ALGS Aligos Therapeutics, Inc. 07 Jul 2022 1 $0 4 Executive Vice President, Chief Scientific Officer 11 Jul 2022, 16:12
ALGS Aligos Therapeutics, Inc. 08 Feb 2022 2 $0 4 Executive Vice President, Chief Scientific Officer 08 Feb 2022, 15:09